We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A Novel Scoring System Based on Fibrinogen and the Neutrophil-Lymphocyte Ratio as a Predictor of Chemotherapy Response and Prognosis in Patients with Advanced Gastric Cancer.
- Authors
arigami, Takaaki; Uenosono, Yoshikazu; Ishigami, Sumiya; Okubo, Keishi; Kijima, Takashi; Yanagita, Shigehiro; Okumura, Hiroshi; Uchikado, Yasuto; Kijima, Yuko; Nakajo, akihiro; Kurahara, Hiroshi; Kita, Yoshiaki; Mori, Shinichiro; Maemura, Kosei; Natsugoe, Shoji
- Abstract
Objective: We assessed the clinical applicability of the F-NLR score, which is based on fibrinogen (F) and the neutrophillymphocyte ratio (NLR), and the Glasgow Prognostic Score (GPS) to predict the therapeutic effects of chemotherapy or chemoradiotherapy on advanced gastric cancer and the prognoses of patients. Methods: Sixty-eight patients with advanced gastric cancer treated with first-line chemotherapy or chemoradiotherapy were classified into two groups based on tumor response. Furthermore, we categorized patients according to cutoff F-NLR scores of 2 [hyperfibrinogenemia (>400 mg/dl) and high NLR (>3.0)], 1 [one of these hematological abnormalities], and 0 [neither hyperfibrinogenemia nor high NLR]. Results: A total of 27 patients had progressive disease (PD) and 41 did not. The F-NLR scores were significantly higher in the PD than in the non-PD group (p = 0.003). Survival was significantly shorter for patients with high F-NLR scores and GPS (p = 0.0071 and p = 0.0065, respectively). Multivariate analysis selected the F-NLR score as an independent prognostic factor (p = 0.017). Conclusion: A novel grading system based on F-NLR scores, as well as the GPS, appears to have value as a clinical predictor of the therapeutic response of advanced gastric cancer to chemotherapy or chemoradiotherapy and the prognoses of patients.
- Subjects
TREATMENT effectiveness; CANCER chemotherapy; CHI-squared test; FIBRINOGEN; LYMPHOCYTES; NEUTROPHILS; ONCOLOGY; RETROSPECTIVE studies; STOMACH tumors; DATA analysis software; DESCRIPTIVE statistics; KAPLAN-Meier estimator; DIAGNOSIS
- Publication
Oncology, 2016, Vol 90, Issue 4, p186
- ISSN
0030-2414
- Publication type
Article
- DOI
10.1159/000444494